Your browser doesn't support javascript.
loading
Safety of a Nurse-Driven Standardized Potassium Replacement Protocol in Critically Ill Patients With Renal Insufficiency.
Conley, Rebecca; Rich, Rebecca L; Montero, Jennifer.
Affiliation
  • Conley R; Rebecca Conley is a critical care pharmacy specialist at BayCare Health System, Tampa, Florida.
  • Rich RL; Rebecca L. Rich is a critical care clinical pharmacy specialist and Director of the specialty pharmacy residency program at Lakeland Regional Health, Lakeland, Florida.
  • Montero J; Jennifer Montero is a clinical quality pharmacy specialist at Lakeland Regional Health.
Crit Care Nurse ; 41(2): e10-e16, 2021 Apr 01.
Article in En | MEDLINE | ID: mdl-33791770
ABSTRACT

BACKGROUND:

In critically ill patients, maintaining appropriate serum potassium concentrations requires careful supplementation to correct hypokalemia but avoid hyperkalemia. At the study institution, an institution-based, nurse-driven standardized electrolyte replacement protocol is used in critically ill patients with a serum creatinine concentration of 2 mg/dL or less. If the serum creatinine concentration is greater than 2 mg/dL, electrolyte replacement requires a physician order.

OBJECTIVE:

To determine if standardized potassium supplementation is safe in critically ill patients with renal insufficiency not requiring renal replacement therapy.

METHODS:

This study was an institutional review board-approved, single-center, retrospective evaluation of critically ill patients receiving intravenous potassium replacement per protocol. Patients were grouped according to serum creatinine concentration (≤ 2 mg/dL or > 2 mg/dL) at the time of replacement. The primary outcome was the incidence of hyperkalemia (potassium concentration ≥ 5 mEq/L) following potassium replacement. Secondary outcomes were the incidence of hyperkalemia, change in serum potassium concentration, and need for hyperkalemia treatment. Outcomes were analyzed using χ2 and t tests.

RESULTS:

Of 814 patients screened, 145 were included (99 with serum creatinine ≤ 2 mg/dL and 46 with serum creatinine > 2 mg/dL). The incidence of hyperkalemia was not different between groups (P = .57). Five patients experienced hyperkalemia; none received hyperkalemia treatment. Change in serum potassium was similar for patients in the 2 groups (P = .33).

CONCLUSIONS:

A standardized, nurse-driven electrolyte replacement protocol can be used safely in critically ill patients with renal insufficiency not requiring renal replacement therapy.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Renal Insufficiency / Hyperkalemia Type of study: Guideline / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Crit Care Nurse Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Main subject: Renal Insufficiency / Hyperkalemia Type of study: Guideline / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Crit Care Nurse Year: 2021 Type: Article